Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Eight Pharma stocks that should be on your radar on Monday
Pharmaceutical companies reported a slew of updates over the weekend. Earnings reactions from KIMS, Global Health, Gland Pharma, Aarti Drugs, to a USFDA observation list for Emcure Pharma, these are the drugmakers that should be on your radar today.
Gland Pharma consolidated net profit rises 96.57% in the March 2026 quarter
Sales rise 22.31% to Rs 1742.79 crore
Gland Pharma Q4 PAT jumps 97% YoY to Rs 367 crore
Gland Pharma reported 96.62% increase in consolidated net profit to Rs 366.7 crore on a 22.31% rise in net sales to Rs 1,742.80 crore in Q4 FY26 over Q4 FY25.
Gland Pharma Declares Rs 20/Share Dividend As Q4 Profit Doubles, Margins Expand; Check Record Date
Gland Pharma Q4
Gland Pharma Q4 profit surges 2x on strong US launches, CDMO growth; declares ₹20 dividend
The board recommended a final dividend of ₹20 per equity share for FY26, subject to shareholder approval. Shares of Gland Pharma Ltd ended at ₹1,861.00, down by ₹34.15, or 1.80%, on the BSE.
Q4 Results LIVE Updates: JSW Steel, Muthoot react to results; Tata Steel, Power Grid report today
Q4 Results LIVE Updates: Two Nifty 50 companies Tata Steel and Power Grid along with broader market names like ITC Hotels, Hindustan Copper, Godfrey Phillips, Gland Pharma, Cochin Shipyard, Deepak Nitrite, Balrampur Chini, Arvind, Bajaj Electricals, Aarti Drugs, Aether Industries, Alembic Pharma, NCC, NHPC, Premier Energies, SAIL, SJVN, Solara Active Pharma, Symphony, Thangamayil, Triveni Engineering, VST Tillers, are among the companies reporting their earnings today. JSW Steel, Muthoot Finance, Apollo Tyres, Endurance Tech, Voltas, are some of the other result reactions today. Watch this space for all the LIVE updates.
Cochin Shipyard, Tata Steel, Power Grid, SJVN, Gland Pharma, NCC Q4 Results Today — Earning Estimates
Tata Steel is expected to report March-quarter earnings with revenue at Rs 62,345.72 crore.
Gland Pharma Ltd gains for third consecutive session
Gland Pharma Ltd is quoting at Rs 1913.1, up 2.27% on the day as on 12:49 IST on the NSE. The stock is up 34.16% in last one year as compared to a 0.68% spurt in NIFTY and a 14.53% spurt in the Nifty Pharma index.
Taking Stock: Bull run on D-Street; Sensex jumps 1,074 pts, Nifty reclaims 24,000
Nearly 150 stocks touched their 52-week high on the BSE, including HFCL, Torrent Pharma, JB Chemicals, Angel One, Vodafone Idea, Polycab, Navin Fluorine, Manappuram Finance, Anand Rathi, KEI Industries, GE Vernova TD, Apollo Hospitals, Gland Pharma, Varun Beverages, Bajaj Auto, Timken, Hindalco Industries, among others.
Trade Spotlight: How should you trade SPARC, Gland Pharma, Techno Electric, GE Power India, Supriya Lifescience, and others on May 25?
A strong move beyond last week's high is required for further market upside; otherwise, range-bound trading may continue. Below are some short-term trading ideas to consider.
Trade Spotlight: How should you trade Gland Pharma, Dr Lal PathLabs, Himadri Speciality Chemical, Axis Bank, JSW Steel, and others on June 12?
The market needs to surpass and sustain above its short-term moving averages for a further uptrend; until then, consolidation may continue. Below are some short-term trading ideas to consider.
Trade Spotlight: How should you trade Authum Investment, Gland Pharma, Thermax, Aurobindo Pharma, Bajaj Auto, and others on May 22?
The market needs a decisive move above the upper end of the 23,300–23,800 range for a fresh leg of rally. Until then, consolidation may continue. Below are some short-term trading ideas to consider.